Pediatric spindle cell/sclerosing rhabdomyosarcoma with FUS-TFCP2 fusion: a case report and literature review.

Autor: Fang Z; Medical Oncology Department, Pediatric Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Clinical Discipline of Pediatric Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China., Duan C; Medical Oncology Department, Pediatric Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Clinical Discipline of Pediatric Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China., Wang S; Department of Otolaryngology Head and Neck Surgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory for Pediatric Disease of Otolaryngology Head and Neck Surgery, Beijing, China., Fu L; Department of Pathology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China., Yang P; Medical Oncology Department, Pediatric Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Clinical Discipline of Pediatric Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China., Yu T; Department of Radiology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China., Deel MD; Department of Pediatrics, Division of Hematology/Oncology, Duke University School of Medicine, Durham, NC, USA., Lau LMS; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Sydney, New South Wales, Australia.; Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia.; Children's Cancer Institute, UNSW Sydney, Sydney, Australia., Ma X; Medical Oncology Department, Pediatric Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Clinical Discipline of Pediatric Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China., Ni X; Department of Otolaryngology Head and Neck Surgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory for Pediatric Disease of Otolaryngology Head and Neck Surgery, Beijing, China., Su Y; Medical Oncology Department, Pediatric Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Clinical Discipline of Pediatric Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China.

Publikováno v: Translational pediatrics [Transl Pediatr] 2024 Jan 29; Vol. 13 (1), pp. 178-191. Date of Electronic Publication: 2024 Jan 24.

Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children's Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force.

Autor: Pacenta HL; Cook Children's Medical Center, Division of Hematology and Oncology, Fort Worth, TX 76014, USA.; Department of Pediatrics and Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Allen-Rhoades W; Division of Pediatric Oncology, Mayo Clinic, Rochester, MN 55902, USA., Langenau D; Molecular Pathology Unit, Massachusetts General Hospital Research Institute, Charlestown, MA 02114, USA., Houghton PJ; Department of Molecular Medicine, Greehey Children's Cancer Research Institute, San Antonio, TX 78229, USA., Keller C; Children's Cancer Therapy Development Institute, Beaverton, OR 97005, USA., Heske CM; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA., Deel MD; Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA., Linardic CM; Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA., Shern JF; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA., Stewart E; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Turpin B; Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA., Harrison DJ; Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Khan J; Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA., Mascarenhas L; Cancer and Blood Disease Institute, Children's Hospital of Los Angeles, Los Angeles, CA 90027, USA.; Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA., Skapek SX; Department of Pediatrics and Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Meyer WH; Department of Pediatrics, Jimmy Everest Section of Pediatric Hematology/Oncology, University of Oklahoma Health Sciences Center, Oklahoma, OK 73104, USA., Hawkins DS; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA 98105, USA., Chen EY; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA., Amatruda JF; Cancer and Blood Disease Institute, Children's Hospital of Los Angeles, Los Angeles, CA 90027, USA.; Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA., Hingorani P; Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Laetsch TW; Department of Pediatrics and Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.; Department of Pediatrics and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA.

Publikováno v: Journal of clinical medicine [J Clin Med] 2021 Apr 01; Vol. 10 (7). Date of Electronic Publication: 2021 Apr 01.

A method to culture human alveolar rhabdomyosarcoma cell lines as rhabdospheres demonstrates an enrichment in stemness and Notch signaling.

Autor: Slemmons KK; Departments of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina., Deel MD; Pediatrics, Duke University School of Medicine, Durham, North Carolina., Lin YT; Pediatrics, Duke University School of Medicine, Durham, North Carolina., Oristian KM; Departments of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina.; Pediatrics, Duke University School of Medicine, Durham, North Carolina., Kuprasertkul N; Duke University, Durham, North Carolina., Genadry KC; Pediatrics, Duke University School of Medicine, Durham, North Carolina., Chen PH; Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina., Chi JT; Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina., Linardic CM; Departments of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina corinne.linardic@duke.edu.; Pediatrics, Duke University School of Medicine, Durham, North Carolina.

Publikováno v: Biology open [Biol Open] 2021 Feb 09; Vol. 10 (2). Date of Electronic Publication: 2021 Feb 09.

RASSF4 is required for skeletal muscle differentiation.

Autor: Lin YT; Department of Pediatrics, Division of Hematology-Oncology, Duke University School of Medicine, Durham, NC, 27710, USA., Deel MD; Department of Pediatrics, Division of Hematology-Oncology, Duke University School of Medicine, Durham, NC, 27710, USA., Linardic CM; Department of Pediatrics, Division of Hematology-Oncology, Duke University School of Medicine, Durham, NC, 27710, USA.; Department of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, NC, 27710, USA.

Publikováno v: Cell biology international [Cell Biol Int] 2020 Feb; Vol. 44 (2), pp. 381-390. Date of Electronic Publication: 2019 Sep 25.

A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas.

Autor: Deel MD; Division of Hematology-Oncology, Department of Pediatrics, Duke University School of Medicine , Durham, NC , USA., Li JJ; Duke University School of Medicine , Durham, NC , USA., Crose LE; Division of Hematology-Oncology, Department of Pediatrics, Duke University School of Medicine , Durham, NC , USA., Linardic CM; Division of Hematology-Oncology, Department of Pediatrics, Duke University School of Medicine , Durham, NC , USA ; Department of Pharmacology and Cancer Biology, Duke University School of Medicine , Durham, NC , USA.

Publikováno v: Frontiers in oncology [Front Oncol] 2015 Sep 02; Vol. 5, pp. 190. Date of Electronic Publication: 2015 Sep 02 (Print Publication: 2015).